Cargando…
Challenges of NTM Drug Development
Discovery and development of antibiotics active against the environmental opportunistic non-tuberculous mycobacteria (NTM) have been retarded by innate antibiotic-resistance of NTM cells and methodological challenges in the laboratory. The basis for the innate resistance of NTM cells is its lipid ri...
Autor principal: | Falkinham, Joseph O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058048/ https://www.ncbi.nlm.nih.gov/pubmed/30072975 http://dx.doi.org/10.3389/fmicb.2018.01613 |
Ejemplares similares
-
Editorial: NTM—The New Uber-Bugs
por: Dartois, Veronique, et al.
Publicado: (2019) -
Host Variability in NTM Disease: Implications for Research Needs
por: Swenson, Colin, et al.
Publicado: (2018) -
Mycobacterium chimaera as an Underestimated Cause of NTM Lung Diseases in Patients Hospitalized in Pulmonary Wards
por: ZABOST, ANNA T., et al.
Publicado: (2021) -
Meeting the challenges of NTM-PD from the perspective of the organism and the disease process: innovations in drug development and delivery
por: van der Laan, Roald, et al.
Publicado: (2022) -
Mykobakterien, nichttuberkulöse (NTM)
por: Rüsch-Gerdes, Sabine, et al.
Publicado: (2009)